• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    argenx SE - American Depositary Shares (NQ:ARGX)

    711.09 -18.67 (-2.56%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 394,184
    Open 723.25
    Bid (Size) 610.00 (1)
    Ask (Size) 1,064.85 (2)
    Prev. Close 729.76
    Today's Range 698.92 - 723.25
    52wk Range 510.06 - 779.03
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Johnson & Johnson Unleashes Triple Threat: Bladder Cancer Breakthrough, Psoriasis Game-Changer, and Myasthenia Gravis Milestone Signal New Pharma Era
    Johnson & Johnson (NYSE: JNJ) is making significant waves in the pharmaceutical landscape, announcing a trio of pivotal developments that underscore its robust pipeline and strategic focus on unmet... 
    Via MarketMinute
    12 Analysts Have This To Say About argenx
     
    Via Benzinga

    Performance

    YTD
    +14.7%
    +14.7%
    1 Month
    +0.4%
    +0.4%
    3 Month
    +27.0%
    +27.0%
    6 Month
    +19.8%
    +19.8%
    1 Year
    +29.5%
    +29.5%

    More News

    Read More
    $1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    argenx SE - ADR (NASDAQ:ARGX) Fits Louis Navellier's 'Little Book' Growth Strategy
    Via Chartmill
    Is argenx Gaining or Losing Market Support?
    Via Benzinga
    Assessing argenx: Insights From 11 Financial Analysts
    Via Benzinga
    United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
    Via Investor's Business Daily
    Topics ETFs
    Why Dianthus Therapeutics, Up 47% In Four Weeks, Just Surged Again
    Via Investor's Business Daily
    3 Healthcare Pathbreakers With Long-Term Tailwinds
    Via MarketBeat
    argenx to Present at Upcoming Investor Conferences
    From argenx SE
    Via GlobeNewswire
    Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today
    Via Benzinga
    Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win
    Via Benzinga
    Regeneron Advances In Rare Disease Race With Positive Autoimmune Muscle Disorder Trial Data
    Via Benzinga
    Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded
    Via Investor's Business Daily
    Topics ETFs
    Argenx Tops Buy Point On Bullish Study, 850 Price Target
    Via Investor's Business Daily
    Argenx Targets FDA Label Expansion After Vyvgart Trial Success
    Via Benzinga
    argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG
    From argenx SE
    Via GlobeNewswire
    ARGENX SE - ADR (NASDAQ:ARGX) Ticks Key Boxes for Growth Investors Using Navellier's 'Little Book' Strategy
    Via Chartmill
    argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025
    From argenx SE
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
    From Pomerantz LLP
    Via GlobeNewswire
    argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis
    From argenx SE
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
    From Pomerantz LLP
    Via GlobeNewswire
    Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today
    Via Benzinga
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
    From Pomerantz LLP
    Via GlobeNewswire

    Frequently Asked Questions

    Is argenx SE - American Depositary Shares publicly traded?
    Yes, argenx SE - American Depositary Shares is publicly traded.
    What exchange does argenx SE - American Depositary Shares trade on?
    argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for argenx SE - American Depositary Shares?
    The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
    What is the current price of argenx SE - American Depositary Shares?
    The current price of argenx SE - American Depositary Shares is 711.09
    When was argenx SE - American Depositary Shares last traded?
    The last trade of argenx SE - American Depositary Shares was at 09/25/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.